United Therapeutics Corp (UTHR): Cost of Revenue
$384.40M
Year ended 2025-12-31
$437.20M
Trailing 12 months to 2026-06-30
+36.4%
3-year compound annual growth
+28.9%
5-year compound annual growth
+18.7%
10-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $384.40M | +24.1% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $309.70M | +20.3% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $257.50M | +69.9% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $151.60M | +23.8% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $122.50M | +13.3% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $108.10M | -8.1% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $117.60M | -40.8% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $198.70M | +88.0% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $105.70M | +45.4% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $72.70M | +5.4% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $69.00M | -45.2% | 2018-02-21, From 2015-01-01 |
| 2014-12-31 | $125.90M | -4.0% | 2017-02-22, From 2014-01-01 |
| 2013-12-31 | $131.13M | +9.9% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $119.30M | +34.2% | 2015-02-24, From 2012-01-01 |
| 2011-12-31 | $88.90M | +31.4% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $67.67M | +65.6% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $40.86M | +51.6% | 2012-02-28, From 2009-01-01 |
| 2008-12-31 | $26.96M | n/a | 2011-02-24, From 2008-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $384.40M | +24.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $717.44M | +23.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $1.91B | +7.4% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $677.17M | +120.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.76B | -2.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.50M | n/a |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $2.12B | +5.9% |
| Organon & Co. (OGN) | 2025-12-31 | $2.90B | +8.0% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.01B | +12.2% |
Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗